Family · Pharmaceutical analytical standards
Albendazole
An anthelmintic of the benzimidazole family, synthesised in 1972 and approved for human use in the early 1980s: it is a mainstay treatment against intestinal worms, including in WHO-backed deworming programmes. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was born in veterinary research: chemist Robert Gyurik synthesised it on his own initiative in about two months, and its first efficacy test was carried out in sheep.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
